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Objectives: Standardization is an important milestone in the validation of DWI as an imaging 
biomarker for renal disease. Here, we propose technical recommendations on three variants of 
renal DWI and associated MRI biomarkers (ADC, IVIM and DTI) to aid ongoing international 
efforts on methodological harmonization.  
Materials and Methods: Reported DWI biomarkers from 194 prior renal DWI studies were 
extracted and Pearson correlations between diffusion biomarkers and protocol parameters were 
computed. Based on the literature review surveys were designed for the consensus-building. 
Survey data were collected via Delphi consensus process on renal DWI preparation, acquisition, 
analysis, and reporting. Consensus was defined as  75% agreement. 
Results: Correlations were observed between reported diffusion biomarkers and protocol 
parameters. Out of 87 survey questions, 57 achieved consensus resolution, while many of the 
remaining questions were resolved by preference (65-74% agreement). Summary of the literature 
and survey data, as well as recommendations for the preparation, acquisition, processing and 
reporting of renal DWI were provided. 
Discussion: The consensus-based technical recommendations for renal DWI aim to facilitate 
inter-site harmonization and increased clinical impact of the technique on a larger scale. We 
anticipate an iterative process with continuous updating of the recommendations according to 
progress in the field.  






Diffusion-weighted (DWI) magnetic resonance imaging (MRI) has been shown to provide 
differentiated information on the microstructure of kidney tissue. Furthermore, significant efforts 
have been made to adopt DWI as a MR-biomarker for functional renal imaging [1-6]. However, 
to successfully translate the research results of renal DWI to clinical practice, there are still some 
challenges to overcome. Firstly, acquisition protocols vary between research groups and reflect 
local practice and expertise. Secondly, patient preparation, data post-processing and image 
analysis are not standardized, with several approaches being used by different research groups. As 
has been recognized by other consortium efforts [7-9], our motivation behind prioritizing 
standardization of these processes is the generation of reliable MRI biomarkers that are ready to 
be broadly utilized in multi-site studies. When achieved, the data generated from standardized 
study protocols will sufficiently increase the evidence base to determine threshold values for DWI-
based parameters, to differentiate between renal pathologies.  Histopathological correlation should 
also continue to be performed to ensure diagnostic validation of the MR biomarkers.  With the aim 
to move towards a standardization and to facilitate the validation of DWI as a renal MRI 
biomarker, an international, multidisciplinary group of renal imaging researchers with experience 
and / or ongoing work in renal DWI was recently formed as part of the ‘PARENCHIMA’ (the 
European Cooperation in Science and Technology) COST action (www.renalmri.org). 
 
As a first step in this endeavour, Caroli et al. [10] published a review and statement paper reflecting 
the current state of research to assess diffuse renal pathology by renal DWI. The work summarizes 
the acquisition protocols used in human renal DWI studies up to August 2017 (172 studies) 




acquisition protocols, patient preparation and image post-processing techniques, as well as the lack 
of “gold standard” for the measurement of in vivo renal DWI. This diversity of acquisition 
protocols across studies has led to a variability of acquired quantitative renal diffusion parameters, 
which is summarized in the detailed supplement material of the review [10]. Therefore, a further 
mission of the PARENCHIMA initiative is building consensus on renal DWI acquisition protocol, 
patient preparation and post-processing techniques. 
 
In this work, a consensus on recommended acquisition protocol for renal DWI was formed 
consistent with the consensus-building goals of the Delphi process [11-13]. The design of the 
surveys for the consensus building was informed by a literature review (extending the prior review 
until November 2018) that aimed to identify which acquisition parameters had the most impact on 
DWI measurements. For the development of the recommendations, the three most common 
variants of renal DWI data used in the literature were considered: 1) monoexponential model with 
parameter apparent diffusion coefficient (ADC); 2) biexponential ADC or IVIM (intravoxel 
incoherent motion) model with the parameters water diffusion in the tissue (D), flowing fraction 
(f) and pseudodiffusion (D*); and 3) diffusion tensor imaging (DTI) with mean diffusivity (MD) 
and fractional anisotropy (FA).  All three variants of renal DWI aim to estimate a diffusion constant 
of water in tissue. However, in all models this diffusion constant is named differently (ADC, D, 
and MD).  ADC quantification methods considering a non-Gaussian DWI signal behaviour are not 
covered in these recommendations given their more preliminary stage of investigation and are not 
deemed as ripe for standardization as the other methods described above. We summarize the three 






This quantification model for DWI MRI is the most popular due to its simplicity and modest 
acquisition requirements. The ADC model assumes a uniform Gaussian displacement distribution 
of the water molecules corresponding to a monoexponential diffusion-weighted signal decay of 




= 𝑒−𝑏𝐴𝐷𝐶𝑚𝑜𝑛𝑜  (1) 
where Sb is the diffusion-weighted signal intensity, S0 is the signal intensity without a diffusion 
weighting (b = 0 s/mm2), b is the diffusion weighting strength (in s/mm2), and ADCmono is the 
apparent diffusion coefficient of water within the observed image voxel. 
 
For renal tissue, the monoexponential model is known to be insufficient to describe the diffusion-
weighted signal decay, with IVIM effects occurring at low b-values (<200 s/mm2) [15] and non-
Gaussian effects possibly occurring at high b-values (>800 s/mm2).  However, as a single 
parameter estimation, the monoexponential model provides relatively robust ADC and requires 
only moderate signal-to-noise ratio on DWI. 
 
Given the contrast effects mentioned above, the estimated ADC is strongly dependent on the 
choice of selected b-values [15,16] and no consensus exists with regard to the choice and number 
of b-values in a renal DWI acquisition protocol. Taking into account Equation (1), a set of 
minimum two b-values is enough to reach a stable diffusion signal [16,17] for the quantification 




including more b-values in the acquisition protocol. Considering possible anisotropic diffusion, it 
is common practice to measure the b-values in several orthogonal directions during the ADC 
acquisition [15,16]. 
 
Intravoxel incoherent motion (IVIM) 
First described by Le Bihan et al. [18] in 1986 the IVIM model is another option to interpret the 
physiological underpinning of the diffusion signal. Since the initial studies in human subjects by 
Muller et.al. in 1998 [19] and later by Thoeny et al. in 2006 [20] showing the potential of the IVIM 
model to interpret diffusion signal in the kidney, this quantification has been demonstrated to 
improve the representation of the diffusion-weighted signal in renal tissue compared to the 
ADCmono [21-23].  
 
IVIM considers the diffusion signal originating from two different compartments. One 
compartment reflects the slow thermal diffusion in the tissue (D), hindered or restricted by local 
microstructure.  The second compartment considers the fast molecule movement associated with 
incoherent flow in the microvasculature or renal tubules that mimics random water motion 
assuming that many vessel and tubules orientations are present within the voxel (quantified by the 
pseudodiffusion, D* and the flowing fraction, f). 
This method of quantification utilizes a biexponential decay, describing the overall diffusion 
weighted signal as the sum of the diffusion and flowing components: 
𝑆𝑏
𝑆0
= (1 − 𝑓) 𝑒−𝑏𝐷 + 𝑓𝑒−𝑏𝐷
∗




where Sb is the diffusion-weighted signal intensity, S0 is the signal intensity without a diffusion 
weighting (b = 0 s/mm2), b is the diffusion weighting strength (in s/mm2), D is the water diffusion 
in the tissue (slow component), D* is the pseudodiffusion (fast component), and  f  is the flowing 
fraction. 
To quantify IVIM parameters, a minimum of four b-values are needed to determine all unknown 
parameters in Equation (2), which typically extends the acquisition time in comparison to the 
monoexponential ADC. Furthermore, there is no universally accepted algorithm yet to calculate 
IVIM quantitative parameters. In many studies, a so-called “segmented fitting” or “2-step” 
approach is used to calculate the IVIM parameters (2), due to its extended stability and faster fitting 
[24-27]. In the “segmented fitting”, a threshold b-value is defined to separate flowing from 
diffusion effects (microcirculation-induced decay assumed negligible above this threshold). 
However, although D is more stable in the “segmented fitting”, than in others, the estimates of f 
and D* can be biased depending on threshold choice.  More recently, Bayesian probability-based 
fitting methods have been explored, with or without fixing of the pseudodiffusion coefficient (this 
has shown higher precision/accuracy, and low inter-subject variability [28]).  
Other, more complex, extended IVIM models can be found in the literature that aim to incorporate 
more characteristics of functioning renal tissue into the signal description. Three compartment 
models include an additional component taking into account multiple sources of intravoxel 
incoherent motion, e.g. due to the glomerular flow [29,30], vascular vs. tubular flow, or residual 
fat signal [31]. Other extended models combine IVIM with diffusion anisotropy for a more 
comprehensive description of both structural and microcirculation features [32,33]. These models 
are mentioned here solely to indicate current research frontiers as they require further investigation 




Diffusion tensor imaging (DTI) 
Measurement of the directional dependence (anisotropy) of apparent diffusion in tissue 
microstructure provides a marker of that tissue’s integrity and thereby of its clinical function. 
Diffusion tensor imaging (DTI) quantitatively measures and maps the anisotropy imposed on water 
diffusion by a tissue`s microstructure.  
 
For DTI analysis, diffusion-weighted signals along several diffusion directions are acquired and 
fit to a 3×3 symmetric tensor model [34,35]. The eigenvalues of this tensor describe the maximal, 
intermediate, and minimal diffusion values, with eigenvectors reflecting their corresponding 
orientation. The primary eigenvector, associated with the largest eigenvalue, indicates the 
orientation of maximal diffusion. Another parameter, called fractional anisotropy (FA) reflects the 
amount of diffusion directivity in DTI studies (0 = complete isotropy, 1 = complete anisotropy), 
while mean diffusivity (MD) is a DTI specific ADC equivalent.  Several studies have demonstrated 
that DTI provides powerful biomarkers of diffusion isotropy in the cortex and anisotropy in the 
renal medulla [15,22,36-43]. This behaviour is consistent with the known structural organization 
of medullary constituents such as the tubular loops of Henle, collecting ducts, and vascular vasa 
recta, which have an inward radial pattern towards the renal pelvis.  
 
As with many diffusion biomarkers, FA and MD depend on the number and magnitude of the 
applied b-values [37,44,41]. As diffusion anisotropy is a key target of DTI, acquisition of multiple 
diffusion directions (minimally 6) is required for tensor computation. However, while some study 




[45], determination of an optimal number or choice of b-values and directions for renal DTI, 
analogous to comprehensive efforts in the brain [28] or muscle [46], has not yet been performed.  
 
Materials and Methods 
Literature review and data extraction 
In order to justify the motivation for the standardization process, assess the state of the renal DWI 
literature, and provide input to subsequent recommendations, we summarize reported DWI 
biomarkers from a wide range of prior renal DWI studies assessing diffuse renal diseases. These 
efforts build upon reviews and meta-analyses that have aimed to understand the variability of 
reported renal diffusion biomarkers in the literature [4,15,23]. 
 
A systematic review and analysis of the literature (using the same search criteria in PubMed as 
previously used by Caroli et al. [10], but extending those until November 2018) was carried out.   
Specifically, papers were categorized according to their protocol and quantification scheme as 
either ADC (113 studies), DTI (40 studies), or IVIM (41studies). From each paper, we extracted 
protocol parameters including full b-value ranges, repetition times (TR), echo times (TE), number 
of gradient directions and field strength. The distribution of b-value ranges was extracted for each 
DWI model for visualization. Additionally, DWI biomarkers were also extracted for cortex, 
medulla, and whole kidney (as available in each study), reporting values in healthy adult controls.  
For each b-value range, the maximum and average b-values were also computed. ADC studies 
provided ADC values [20,21,42,47-61], DTI studies provided MD and FA values [29,32,33,62-





Following data extraction, correlations were computed in healthy volunteers only via Pearson 
correlation coefficients with the following protocol parameters: (1) TR; (2) TE; (3) average b-
value; (4) maximum b-value; (5) transverse relaxation factor T2 = exp (-TE/T2t) ; (6) T1 = (1-exp 
(-TR/T1t)), where T2t = 87 ms and T1t = 1147 ms were taken as representative relaxation times 
for renal tissue at 3.0 T [81]. After correlation with individual protocol parameters, correlations 
were computed between diffusion biomarkers and all possible products or ratios of the protocol 
parameters (52 combinations in all). Correlation coefficients R and significance levels p were 
derived for each correlation using the Igor Pro 7 software (Wavemetrics, Inc., Lake Oswego, OR 
USA). Significant correlations were noted both without (p<0.05) and with Bonferroni correction 
for multiple comparisons (p<0.05/52=0.00096). Finally, all diffusion biomarkers from healthy 
volunteers were grouped according to field strength (1.5 T or 3.0 T) and compared for differences 
with a two-tailed Student’s t-test, for which significant differences are indicated for p<0.05. 
 
Description of survey process 
As described in the accompanying covering letter by Sourbron et al. and in keeping to the 
‘approximation of a two-step modified Delphi method [82]’ for consensus-building, a survey was 
circulated using a publicly available tool (Google Forms) to a range of renal imaging researchers 
with experience and / or ongoing activity in renal diffusion imaging.  In addition to offering 
participation to all members of the PARENCHIMA collaboration, every effort was made to invite 
at least one researcher or corresponding author from each group contributing to the literature as 
surveyed previously [10]. Two rounds of surveys were circulated over a period of 4 months. 
Between the first and second circulation and following review of initial results with the ASL, 




avoid ambiguity and increase the likelihood of reaching consensus on as many items as possible. 
The surveys included questions on:  Respondent training, Patient preparation, Image acquisition, 
Diffusion parameters, Analysis, and Reporting. The full list of questions from the final circulation 
is provided in the Results section along with summarized results, percentage agreement, no basis 
and disagreement for all responses, as well as percentage agreement and disagreement without 
abstentions. Nearly all questions tested level of agreement or disagreement qualitatively. In the 
first circulation, 5 options were provided (Strongly agree / Agree / Neutral / Disagree / Strongly 
Disagree).  In the second circulation the available responses were simplified and allowed for 
abstention (Agree / Disagree / I have insufficient experience to make a recommendation). Other 
questions focused on the preferred field strength or allowed multiple selections to test support of 
multiple related issues (e.g. reported parameters). Text comments were also collected on sets of 
questions of similar topics. For both rounds, responses were aggregated following the completion 
of the survey. The first round survey was issued on 1/11/19, and the second on 3/27/19; both were 
open for approximately 1 month. 
   
After excluding abstentions, the level of agreement or disagreement as a percentage of all 
responses was calculated for each question. Responses for which either agreement or disagreement 
reached 75% or higher were deemed to have achieved consensus. Responses that related to one 
that has already reached consensus were deemed to have been resolved. For responses with 
agreement levels between 60% and 75%, a ‘preference’ was indicated but without the full weight 
of consensus. Similarly, other responses mutually exclusive from a preference or reaching lower 




Finally, the combination of all of these directly or indirectly resolved questions were considered 




Figure 1 shows the distributions of b-value sampling and diffusion directions from all renal studies 
considered (control and patient-related). ADC and IVIM studies have featured a continuous range 
of b-values, while DTI studies have used a sparser selection, consistent with more time devoted to 
directional sampling. Finally, the majority of ADC and IVIM studies used 3 orthogonal directions 
for isotropic imaging.  Since many of these studies employ inline processing with vendor software, 
the 3 directions are typically immediately averaged, both for convenience and for enhanced signal-
to-noise ratio, to generate approximate ‘trace-weighted’ images prior to generation of ADC maps.   
DTI studies used six directions most often, but studies using as many as 30 directions have also 
been reported. While 6 directions is the bare minimum required for tensor calculation, other 
supplemental criteria have been suggested; for example, a minimum of 12 directions has been 
suggested to eliminate orientation bias in tensor results [83]. It should be noted that overall 
parameter estimation quality depends strongly and nonlinearly on the signal-to-noise ratio (SNR): 
it is essential that the SNR is considerably higher than a critical SNR. This critical SNR is about 8 
for medium and high IVIM perfusion and 50 for the low IVIM perfusion regime [17].   
 
Table 1 shows the results of the diffusion biomarker vs. protocol parameter correlations in healthy 
volunteers.  All correlation results are shown for individual protocol parameters and biomarkers, 




correlation coefficients. The primary protocol element correlation with reported diffusion 
biomarkers is average b-value, which significantly correlated negatively with tissue diffusivity D 
(Cx (cortex): R = -0.506, p = 0.03; Md (medulla): R = -0.528, p = 0.02) and positively with flow 
fraction f (Cx: R = 0.687, p = 0.002; Md: R = 0.566, p = 0.01). These correlations may have 
contributions from partial sampling of the IVIM signal response, with higher b-value ranges 
providing better estimates of both slow and fast diffusion components. Conversely, if b-values are 
sampled beyond the appropriate SNR level, Rician noise bias can lower ADC or D values and 
inflate f values. Similar negative correlation trends (p < 0.1) are seen between cortical ADC (R = 
-0.378, p = 0.08) or cortical MD (R = -0.531, p = 0.05) and maximum b-value. Transverse 
relaxation effects cause secondary correlations of flowing fraction with echo time TE (R = 0.474, 
p = 0.055) or equivalently T2 decay factor (R = -0.495, p = 0.04), likely due to reduction of the 
more rapidly relaxing tissue compartment, as quantified by Lemke et al. [17], and supported by 
the disparate relaxation times of renal tissue [81] and serum blood [84] or urine [85-87]. Another 
potential modulator of contrast is diffusion time, which is lengthened at larger echo time, though 
the role of this parameter in renal tissue has not been conclusively mapped out. Combining b-value 
and sequence timing factors together showed some amplified correlations, particularly for flow 
fraction and tissue diffusivity. In some cases, increasing T1 recovery increased flow representation 
and therefore higher f and ADC. Finally, a combination of relaxation factors and average b-value 
showed a negative correlation trend (R = -0.463, p = 0.07) with medullary FA, consistent with a 
modulation in flow effects on diffusion anisotropy. Figure 2 shows example correlations between 
renal DWI biomarkers in the literature and protocol parameters. As these variations of acquisition 
protocols and DWI biomarkers should be avoided in the translation of renal DWI to clinical 




existing work to facilitate multi-site consistency through standardized acquisition, analysis, and 
reporting guidelines. 
 
Table 2 shows summarized diffusion biomarkers in cortex and medulla in healthy volunteers from 
the literature review, stratified by field strength (1.5 T or 3.0 T).  The only cases showing 
significant differences were IVIM pseudodiffusion (D*) and DTI mean diffusivity (MD) in cortex, 
both of which were higher at 1.5 T than 3.0 T.   
 
Survey results 
The second-round survey included 21 respondents from 21 institutions in 8 different countries on 
3 continents. 9 of 21 (43%) were radiologists, while 13/21 (57%) were physicists (11), biomedical 
engineers (1), or mathematicians (1). 71% of the respondents used renal diffusion for volunteer 
research, 76% used it for patient research, 38% used it for clinical practice, and 14% used it for 
clinical trials.   
 
For the second-round survey, among the 87 questions testing levels of agreement, 23 reached 
consensus agreement and 18 reached consensus disagreement. These results also resolved 16 other 
questions on the same topics as the “parent” consensus questions. For the remaining questions, if 
preferences are made for 17 questions, the remaining 13 questions are resolved. The fully 
aggregated survey responses, as well as text comments provided, are included as supplementary 
material, with Table 3 summarizing results of agree / disagree questions (with those reaching 
consensus highlighted).  Regarding magnetic field strength, a consensus majority (81%) responded 




details (matrix, image orientation, fat suppression mode, averages, slice thickness, resolution, field 
of view, TR, TE, number and choice of b-values, and number of directions) received consensus 
support to be reported. Reporting biomarkers in both cortex and medulla was supported by 
consensus. Regarding processing, motion correction algorithm, processing software, IVIM fit 
algorithm, and IVIM fit option received consensus support to be reported. Regarding biomarkers’ 
summary statistics, mean, median, and standard deviation values received consensus support to be 
reported.  There are a range of topics that did not reach the level of consensus, including slice 
thickness, repetition time TR, number of signal averages, breathing mode, separate vs. combined 
protocols, diffusion gradient waveform, the number and highest b-value employed, number of 
diffusion directions for DTI, and aspects of ROI prescriptions.   
 
Considering the literature trends, consensus views, preferences, comments and practical aspects 
surrounding future evidence generation, recommendations are given in Table 4 for ADC, IVIM, 
and DTI protocols.  For many of the issues guiding protocol selection, the survey process provided 
clear indications of consensus choices (Table 3). For those topics not reaching consensus, we 
combine lesser-weighted preferences, practical issues, and information from text survey responses 
to synthesize recommendations.  For acquisition, the consensus includes pulse sequences, RF coils, 
in-plane matrix / resolution, slice coverage, parallel imaging acceleration, fat suppression, echo 
time, and absence of cardiac gating.  Strong preference (62%) was given for > 4 mm slice 
thickness, though some respondents expressed a desire for lower values when feasible. Strong 
preference (67% agreement) was also given for a TR=2-4 s. Given some contribution of T1 
weighting to parameter variability, we have suggested a standardized repetition time TR = 4 s. 




respiratory gating and free breathing (66%). Free breathing was noted to be acceptable in cases of 
renal allograft imaging. We have recommended respiratory gating when available and free 
breathing with post-hoc unilateral motion correction when not available (which was separately 
recommended by consensus). Regarding field strength, consensus approval for either 1.5 T or 3.0 
T was found (81%), and only minimal differences were observed in the literature (Table 2). The 
SNR advantage of higher field is balanced by other disadvantages for DWI such as susceptibility-
induced image distortion. Correspondingly, either field strength is deemed acceptable and 
investigators suggested to employ whichever is better equipped with hardware or software 
elements consistent with recommendations herein.   
 
Discussion 
The design of diffusion MRI protocols for renal imaging remains controversial, with some support 
for separate protocols for each diffusion technique and slightly more support for combined 
protocols. Similarly, separate protocols for ‘standardized’ efforts and exploratory research had 
only 50% support. Since deriving all measures from a combined protocol requires more 
sophisticated workflows than are universally available and consistent with the goals of generating 
generalizable evidence, we have thus recommended parsimonious protocols for ADC, IVIM, and 
DTI studies. As noted below, however, the encoding parameters suggested have commonalities 
(e.g. b-values) that may allow pooling of analogous biomarkers and consistency with advanced 
protocols involving combined encoding. 
 
Diffusion weighting (choice of b-values) is a crucial element of diffusion MRI protocols. For ADC 




strong preference for a maximum b-value of 800 s/mm2. For IVIM studies, consensus was found 
for a number of b-values greater than 6 b-values, with highest preference for more than 8. Finally, 
for DTI studies, preference was given to more than 2 b-values (61%), with a maximum b-value of 
600 s/mm2 (59%). 6 directions were deemed insufficient for DTI (76%), with a slight preference 
for more than 12 directions (63%). In addition to these indications from our panel, we may also 
take guidance from optimization studies on renal DWI sampling [16,17] that emphasized the 
importance of several key b-value regimes: low (0-200 s/mm2) intermediate (200 - 400 s/mm2), 
and high (600-800 s/mm2).   Finally, we deem it valuable to suggest common encoding parameters 
between techniques (ADC, IVIM, DTI) where possible to enable reasonable comparison of 
analogous MRI biomarkers (e.g. ADC and MD) in future datasets. Taking all of this into account, 
we recommend the following b-value sets (Table 4): for ADC studies, b = 0, 100, 200, 800 s/mm2, 
3 directions; for IVIM studies b = 0, 30, 70, 100, 200, 400, 800 s/mm2, 3 directions; for DTI 
studies, b = 0, 200, 800 s/mm2, 12 or more directions.   
 
Manual ROI placement had consensus support over automatic (e.g. histogram-based) placement, 
with the unweighted (b = 0) image having consensus support for ROI prescription. Cortical ROIs 
should be continuous stripes (1 per slice), unless structural abnormalities prevent this, while 
medullary ROIs should be separate, with three regions sampled (upper, middle, lower poles). 
Generally, all slices from whole kidney coverage should be sampled with the exception of the 2 
outermost slices where region delineation may be unclear.   
 
We acknowledge some limitations in the procedures used to generate recommendations in this 




population size or technological availability. Heterogeneity also exists in the survey process, in 
which participant elections may have been driven by different priorities and informed by different 
levels of clinical or technical experience. In addition, while we modeled our approach on the 
Delphi consensus procedure, its application was adjusted for the purposes of this review and its 
timeframe.  The survey also highlighted other areas of disagreement between the participants. In 
particular, it was not possible to obtain a consensus on technical questions like the use of 
segmented echo planar acquisitions, or the advantage of bipolar diffusion gradients. Uncertainty 
exists also for physiological questions such as the effect of diet on DWI.  As some of these issues 
have already been partly addressed in the literature, the survey indicates that currently available 
evidence may not be sufficient for conclusive resolution. This report should therefore motivate a 
significant effort to investigate theses dedicated methodological questions. 
 
Conclusions 
The present work has summarized trends in the literature of renal diffusion MRI to date and their 
correlation with aspects of protocol design. In pursuit of minimizing this inter-study and inter-site 
variation, for the generation of evidence basis for reliable and high impact of imaging markers for 
renal disease, and with the guidance of a Delphi-based consensus process of experts in the field, 
we have generated a set of recommendations for future data collection. These protocols have been 
chosen to be achievable by any center and enable future pooling of data from multiple centers 
when equivalent protocols have been employed. We expect that this recommendation process to 
be an iterative one and ensuing efforts may refine or add to these recommendations. Importantly, 
these translational efforts do not replace and are not in conflict with ongoing innovation efforts to 




reflect a view that commitment of some effort to generating generalizable workflows in parallel 
will yield tremendous benefits to the field as a whole and increase chances of clinical impact on a 
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  ADC D f D* MD FA 
  R p N R p N R p N R p N R p N R p N 
Ave b-val 
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TE 
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Aveb * TE 
Cx 0.007 0.98 19 -0.338 0.19 17 0.713 0.001 17 -0.395 0.23 11 -0.168 0.57 14 0.086 0.75 16 
Md 0.506 0.046 16 -0.331 0.20 17 0.501 0.04 17 -0.457 0.16 11 0.001 1.0 14 -0.216 0.42 16 
Aveb*T2f 
Cx -0.067 0.78 19 -0.701 0.003 17 0.435 0.08 17 -0.184 0.59 11 -0.106 0.72 14 0.200 0.46 16 
Md 0.107 0.69 16 -0.741 0.001 17 0.559 0.02 17 -0.228 0.50 11 0.167 0.57 14 -0.357 0.18 16 
Aveb*T2f/
T1f 
Cx 0.262 0.37 14 -0.479 0.05 17 0.223 0.39 17 -0.338 0.31 11 0.141 0.63 14 0.030 0.91 16 
Md 0.175 0.59 12 -0.503 0.04 17 0.427 0.09 17 -0.340 0.31 11 0.253 0.38 14 -0.463 0.07 16 
Aveb*T1f/
T2f 
Cx 0.691 0.006 14 -0.381 0.13 17 0.682 0.003 17 -0.174 0.61 11 -0.269 0.35 14 0.133 0.63 16 
Md 0.660 0.02 12 -0.369 0.15 17 0.477 0.05 17 -0.240 0.48 11 -0.049 0.87 14 -0.204 0.45 16 
Maxb*T1f
/T2f 
Cx 0.110 0.71 14 -0.155 0.55 17 0.547 0.02 17 0.171 0.62 11 -0.539 0.047 14 0.088 0.75 16 
Md 0.293 0.36 12 -0.150 0.57 17 0.310 0.23 17 0.236 0.48 11 -0.015 0.96 14 -0.163 0.55 16 
 
Table 1 : Correlations between reported renal diffusion metrics in the literature from cortex (Cx) or medulla (Md) regions of healthy volunteer kidneys and the 
corresponding studies’ protocol parameters average b-value (ave b-val), maximum b-value (max b-val), echo time (TE), repetition time (TR), T2-weighting factor 
(T2f), and T1-weighting factor (T1f) (see text for calculation of relaxation weighting factors).  Pearson correlation coefficients R, significance levels from two-
sided t-test p, and number of studies contributing N are shown for the following diffusion parameters : apparent diffusion coefficient (ADC), IVIM tissue 
diffusivity (D), IVIM flow fraction (f), IVIM pseudodiffusivity (D*), DTI mean diffusivity (MD), and DTI fractional anisotropy (FA).  Significant correlations 
(p<0.05) are highlighted in bold, moderate trends (p<0.1) in italics. 
  
   ADC D f D* MD FA 
Cortex 
1.5 T 
Mean +/- s.d. 2056 ± 285 1966 ± 72 19.9 ± 3.2 50800 ± 13454 2508 ± 86 0.208 ± 0.045 
N 12 7 7 4 4 4 
3.0 T 
Mean +/- s.d. 2243 ± 225 1919 ± 229 20.1 ± 8.4 24964  ± 20298 2262 ± 164 0.215 ± 0.043 
N 10 11 11 8 10 12 
 p 0.100 0.538 0.944 0.028 0.004 0.779 
Medulla 
1.5 T 
Mean +/- s.d. 1987 ± 267 1884 ± 76 17.5 ± 5.5 57350± 25505 2348 ± 589 0.425 ± 0.079 
N 8 7 7 4 4 4 
3.0 T 
Mean +/- s.d. 2031 ± 227 1796 ± 228 18.0 ± 7.8 29016 ± 19272 2092 ± 162 0.335 ± 0.082 
N 9 11 11 8 10 12 
 p 0.721 0.261 0.877 0.110 0.452 0.105 
 
Table 2 : Comparisons between reported renal diffusion metrics in the literature from cortex or medulla regions of healthy volunteer kidneys at different field 
strengths (1.5 or 3.0 T).  Mean and standard deviation values, significance levels from two-sided t-test p, and number of studies contributing N are shown for the 
following diffusion parameters : apparent diffusion coefficient (ADC), IVIM tissue diffusivity (D), IVIM flow fraction (f), IVIM pseudodiffusivity (D*), DTI mean 
diffusivity (MD), and DTI fractional anisotropy (FA).  Significant field differences (p<0.05) are highlighted in bold.  ADC, D, D*, and MD values are given in 10-6 
mm2/s, f is given in %, and FA is unitless.  







% Agree % Disagree 
 
Diet needs to be controlled before the scan 
33.3 28.6 38.1 46.7 53.3  
Subject should be scanned in a normal hydration 
status when clinically appropriate 
76.2 19.1 4.8 94.1 5.9 
Agree 
Subjects are required to follow a controlled and 
standardized salt intake before the scan 
4.8 42.9 52.4 8.3 91.7 
Disagree 
 
      
Single-shot echo planar imaging sequence 
100 0 0 100 0 Agree 
Multi-shot echo planar imaging sequence 
28.6 33.3 38.1 42.9 57.1  
RF body  matrix coils 
95.2 4.8 0 100 0 Agree 
Axial slice orientation 
28.6 4.8 66.7 30 70 Disagree 
Coronal slice orientation (consistent with above) 
42.9 9.5 47.6 47.4 52.6  
Oblique coronal slice orientation along long kidney 
axis (consistent with above) 
76.2 0 23.8 76.2 23.8 
Agree 
 
      
Acquired matrix size >128 
85.7 0 14.3 85.7 14.3 Agree 
Inplane resolution 2 mm or smaller 
19.1 0 81.0 19.1 81.0 Disagree 
Inplane resolution between 2 and 3 mm 
90.5 0 9.5 90.5 9.5 Agree 
Inplane resolution > 3 mm 
4.8 9.5 85.7 5.3 94.7 Disagree 
Slice thickness 2 mm or less 
0 9.5 90.5 0 100 Disagree 
Slice thickness between 2 and  4 mm 
57.1 4.8 38.1 60 40 Agree 
Slice thickness > 4 mm 
61.9 0 38.1 61.9 38.1 Agree 
 
      
Gap between slices 
42.9 4.8 52.4 45 55  
Full kidney slice coverage 
90.5 0 9.5 90.5 9.5 Agree 
Parallel imaging acceleration (factor 2) 
95.2 0 4.8 95.2 4.8 Agree 
Parallel imaging acceleration (factor > 2) (consistent 
with above) 
19.1 23.81 57.1 25 75 
Disagree 
 
      
SPAIR fat suppression 
61.9 23.8 14.3 81.3 18.8 Agree 
STIR fat suppression (consistent with above) 
9.5 28.6 61.9 13.3 86.7 Disagree 
 
      
2000 ms< TR < 4000 ms 
66.7 0 33.3 66.7 33.3 Agree 
TR > 4000 ms 
38.1 4.8 57.1 40 60 Disagree 
 
      
TE < 100 ms 
95.2 0 4.8 95.2 4.8 Agree 
TE minimum allowed by hardware / sequence 
85.7 9.5 4.8 94.7 5.3 Agree 
 
      
2 signal averages 
38.1 4.8 57.1 40 60 Disagree 
3 signal averages 
66.7 0 33.3 66.7 33.3 Agree 
 
      
Expiration Breathhold acquisition 
9.5 4.8 85.7 10 90 Disagree 
Free breathing acquisition  (consistent with above) 
66.7 0 33.3 66.7 33.3 Agree 
Respiratory gated acquisition (consistent with above) 
66.7 4.8 28.6 70 30 Agree 
 
      
Cardiac gating (systole) 
0 33.3 66.7 0 100 Disagree 
Cardiac gating (diastole) 
4.8 33.3 61.9 7.1 92.9 Disagree 
 
      
Separate acquisitions for ADC / IVIM vs. DTI studies 
in a multiparametric protocol 
42.9 9.5 47.6 47.4 52.6 
 
Separate protocols for multiparametric acquisitions and 
exploratory renal diffusion MRI research 
47.6 4.8 47.6 50 50 
 
Single protocol to provide all metrics (ADC, DTI, 
IVIM) 
47.6 14.3 38.1 55.6 44.4 
 
 
      
Monopolar diffusion gradients 
57.1 19.1 23.8 70.6 29.41 Agere 
Twice-refocused Bipolar diffusion gradients 
28.6 42.9 28.6 50 50  
 
      
DWI sequence with only 2 b-values 
14.3 0 85.7 14.3 85.7 Disagree 
DWI sequence with more than 2 b-values 
90.5 0 9.5 90.5 9.5 Agree 
 
      
ADC studies : include low b-values < 200 s/mm2 
85.7 0 14.3 85.7 14.3 Agree 
 
      
ADC studies : highest b-value 600 s/mm2  
19.1 0 81.0 19.1 81.0 Disagree 
ADC studies : highest b-value 800 s/mm2 (consistent 
with above)  
61.9 0 38.1 61.9 38.1 
Agree 
ADC studies : high b-value 1000 s/mm2 (consistent 
with above) 
28.6 4.8 66.7 30 70 
Disagree 
 
      
IVIM studies : 4 b-values 
0 9.5 90.5 0 100 Disagree 
IVIM studies : 6 b-values 
19.1 9.5 71.4 21.1 78.9 Disagree 
IVIM studies : 8 b-values 
47.6 9.5 42.9 52.6 47.4  
IVIM studies : > 8 b-values 
52.4 4.8 42.9 55 45  
 
      
DTI studies : 2 b-values 
38.1 28.6 33.3 53.3 46.7  
DTI studies: > 2 b-values 
38.1 38.1 23.81 61.51 38.5 Agree 
 
      
DTI studies : highest b-value 400 s/mm2 
4.8 28.6 66.7 6.7 93.3 Disagree 
DTI studies : highest b-value 600 s/mm2 
47.6 19.1 33.3 58.8 41.2  
DTI studies : highest b-value 800 s/mm2 
38.1 23.8 38.1 50 50  
DTI studies : highest b-value 1000 s/mm2 
9.5 28.6 61.9 13.3 86.7 Disagree 
 
      
DTI studies : 6 directions 
19.1 19.1 61.91 23.51 76.5 Disagree 
DTI studies : 12 directions 
42.9 28.6 28.6 60 40 Agree 
DTI studies : > 12 directions 
47.6 23.8 28.6 62.5 37.5 Agree 
 
      
Post-hoc EPI distortion correction 
52.4 38.1 9.5 84.6 15.4 Agree 
Post-hoc motion correction / registration 
90.5 9.5 0 100 0 Agree 
Unilateral motion correction / registration 
47.6 38.1 14.3 76.9 23.1 Agree 
 
      
Manual ROI placement 
85.7 9.5 4.8 94.7 5.3 Agree 
Manual ROI placement on ADC map 
42.9 9.5 47.6 47.4 52.6  
Manual ROI placement on b0 
76.2 9.5 14.3 84.2 15.8 Agree 
Manual ROI placement on FA map 
42.9 14.3 42.9 50 50  
 
      
Manual continuous cortical stripe ROI per slice 
47.6 19.1 33.3 58.8 41.2  
Manual Whole medulla ROI per slice 
23.8 19.1 57.1 29.4 70.6 Disagree 
Manual Whole kidney ROI per slice 
33.3 14.3 52.4 38.9 61.1 Disagree 
Manual Multiple medulla ROI per slice 
76.2 9.5 14.3 84.2 15.8 Agree 
Manual Multiple cortical ROIs per slice 
52.4 9.5 38.1 57.9 42.1  
If multiple, Three cortical ROIs per slice 
38.1 19.1 42.9 47.1 52.9  
If multiple, Three medulla ROIs per slice 
47.6 19.1 33.3 58.8 41.2  
If multiple, >Three cortical ROIs per slice 
28.6 14.3 57.1 33.3 66.7 Disagree 
If multiple, >Three medullary ROIs per slice 
33.3 14.3 52.4 38.9 61.1 Disagree 
 
      
If multiple slices, 3 slices sampled 
52.4 9.5 38.1 57.9 42.1  
If multiple slices, >3 slices sampled 
57.1 9.5 33.3 63.2 36.8 Agree 
 
      
Automatic ROI placement, based on b0 histogram 
23.8 38.1 38.1 38.5 61.5 Disagree 
Automatic ROI placement, based on ADC 
histogram 
14.3 42.9 42.9 25 75 
Disagree 
Automatic ROI placement, based on FA histogram 
19.1 42.9 38.1 33.3 66.7 Disagree 
 
      
Report diffusion biomarkers in cortex 
95.2 4.8 0 100 0 Agree 
Report diffusion biomarkers in medulla 
90.5 9.5 0 100 0 Agree 
Report diffusion biomarkers in whole kidney 
38.1 14.3 47.6 44.4 55.6  
 
      
Diffusion units 10^-3 mm2/s 
81.0 0 19.1 81.0 19.1 Agree 
Diffusion units 10^-6 mm2/s 
28.6 0 71.4 28.6 71.4 Disagree 
Diffusion units microns^2/ms 
14.3 0 85.7 14.3 85.7 Disagree 
 
      
Colormap presentation 
76.2 0 23.8 76.2 23.8 Agree 
Grayscale map presentation 
61.9 0 38.1 61.9 38.1 Agree 
Parametric map fusion with anatomic imaging 
61.9 9.5 28.6 68.4 31.6 Agree 
Table 3 : Summary of survey results on agree / disagree questions.  Questions highlighted in bold achieved consensus (>= 75%).  The choice on each question 


























Protocol option Recommendation Weight 
Preparation Normal hydration  
Field strength 1.5 T or 3.0 T  
Sequence Single shot EPI  
Orientation Oblique coronal  
Matrix >128  
In-plane resolution 2-3 mm  
Slice thickness >4 mm  





Fat suppression SPAIR  
TR (s) 4  
TE (ms) Min ( < 100)  
Averages 3  
Breathing mode Respiratory gated  
(or free breathing with post-hoc motion correction) 
 
Cardiac gating no  
Diffusion gradients Monopolar  
 ADC IVIM DTI  
# b-values 4 >6 >2  
Suggested b-values 0,100,200,800 0,30,70,100,200,400,800 0,200,800  
# directions 3 3 12 or more  










ROI placement b=0 image  
Cortical ROI 1 stripe / slice ;> 3 slices  
Medullary ROI 3 samples / slice ;> 3 slices  
Reporting Cortex and Medulla  
Metric statistics 
reporting 
Mean, Median, Standard deviation, ROI size 
 
Diffusion units 10-3 mm2 / s  
Map format Colormap , fused with anatomy if possible  
Table 4: Recommendations for acquisition and processing of renal DWI data.  Recommendations in bold are derived from consensus view of the 
expert panel.  Weight of each recommendation is color coded (green = consensus (>=75%) ; orange = preference (>=60%). 
 
Figure 1 : Distributions of diffusion MRI sampling in renal DWI literature studies. b-value distributions used in studies reporting (a) ADC values, (b) 
DTI metrics, or (c) IVIM metrics. In the ‘bubble’ plots, the size of the circle reflects the amount of studies utilizing that b-value.  (d) Distribution of 





Figure 2: Correlations between renal diffusion MRI metrics and protocol parameters from the literature from cortex, medulla, and whole kidney 
tissue in healthy adults.  (a) ADC, (b) IVIM tissue diffusivity D, (c) DTI fractional anisotropy FA, and (d) IVIM flow fraction f vs. average or 
maximum b-value with relaxation weighting terms.  Inter-study variation can be reduced when desired for larger evidence generation using more 
standardized protocols.    
Comments (diet) 
We use it along with other techniques like BOLD and ASL and so we always prefer to use at least 4 hr fasting. 
It may help to reduce susceptibility artifacts from bowel gas if subjects avoid large meals, fiber, red meat 24 hrs before scan. 
Hydration 
Avoiding a high protein diet before the scan and having light meals 24 hours before the examination would be helpful (this would also reduce colonic loading that 
might interfere with the MRI acquisition). 
Not possible in daily routine. 
DWI may be frequently performed along with other techniques such as BOLD which will require some standardization of diet/water intake. 
 
Comments (hydration) 
Hydration has an influence over diffusion parameters. 
Normal hydration level (1 glass water) suggested 
Standard hydration should be preferred 
This should be guided by eliciting clinical history on the day of the scan - anything between 250 - 500 ml of water would be appropriate if no clinical contra-
indications (such as existing oedema, etc). 
 
Comments (salt intake) 
Seems difficult to control, would need a very specific list of allowed/forbidden foods and quantities. 
This would be difficult to achieve for patients that are not already on a controlled diet and the non-compliance rate would be high (as well as potentially result in 
failures of patient recruitment). 
 
Comments (k-space readout) 
I have always used single-shot EPI 
Speed is an issue with multi echo shot EPI 
This should be guided by the information available in the current literature that yields best image quality. 
 
Comments (field strength) 
Higher distortion in coronal at 3T 
3T preferred when available. 
 
Comments (image orientation) 
Coronal. Oblique not mandatory but definitely an option in particular if simplifies matching geometry to other MR acquisitions as part of a multiparametric 
protocol. The TRs are normally long enough to allow full kidney coverage even if doing pure coronal (i.e. no oblique). 
As part of multiparametric approach, it makes sense to have all the acquisitions in the true coronal plane. 
Axial minimizes distortion, but coronal to scanner or the kidney matches the other sequences in an multiparametric MRI protocol. 
Long axis alignment (using anatomic referencing) best chance for standardized regional sampling 
Oblique coronal slice orientation along long kidney axis (for native kidneys), axial plane for transplanted kidneys 
In-plane motion preferred 
Ideally the DWI acquisition should match and be "mapped" to anatomical imaging / other MRI pulse-sequence acquisitions so that renal mpMRI protocols 
become. reality. 
We do axial DWI and coronal DTI. In our experience, for quantitative imaging, straight axial and straight coronal works well with consistency in clinical practice. 
With oblique, there is potential to automatically increase TE if FOV gets changed due to patient size or if the angle gets steep. 
Oblique coronal slice orientation along long kidney axis should be done with two independent slice packages, one aligned to the left and one aligned to the right 
kidney. 
I think would be reasonable to acquire both axial and oblique coronal. 
In my opinion all orientations can be used. 
 
Comments (image matrix) 
Depends on FOV 
agree, with lower than 128, the spatial resolution is too low. 
 
 
Comments (inplane resolution) 
High resolution (2mm or smaller) would increase the acquisition time and the noise; low resolution (>3mm) would be not enough. 
SNR is an issue with high inplane resolution. 
 
Comments (slice thickness) 
 [4-5] mm 
Ideally it would be great to have slice thickness between 2 and 4mm, but taking into account the time limitation even 5-6mm could be enough (I vote for saving 
time using higher slice thickness and use it for acquiring more b values). 
Higher SNR, more kidney coverage in fewer slices and less acquisition time. 
Large slice helpful for sufficient SNR in advanced protocols. 
SNR again an issue. 
Slice thickness>4 mm increases SNR 
We make every effort to use 3mm in general. although 4 mm has been occasionally used clinically for speed if running out of time. 
 
Comments (slice coverage) 
More than 1 slice, e.g. 3 slices. 
 
Comments (parallel imaging) 
I have always used factor = 2 - no experience with factors>2 
For EPI, parallel imaging will reduce effective TE and potentially reduce artifacts 
If sufficient snr eg at 3t 
factor>2 makes images noisy with the current acquisition method. perhaps something to reconsider in future, in combination with SMS or CS. 
2 or higher 
 
 
Comments (fat suppression) 
Is an option for a spectrally selective method missing? I normally use that at 3T with acceptable results (i.e. the so called FatSat on Siemens) 
I have always used SPAIR fat suppression (called ASPIR on GE scanners) 
With EPI, fat suppression is essential 
 
Comments (TR) 
Collected respiratory triggered 
[4-5] s 





Should be guided by hardware capabilities. 
as long as it is consistent. 
 
Comments (signal averages) 
Depends on no. directions / scan time / bval. If time allows do multiple averages particular at the highest bvals. Can also allow retrospective rejection of corrupted 
volumes (e.g. dropout) 
It's again a matter of acquisition time, as having 2 averages doubles the acquisition time. We prefer to use just 1 average and acquire a higher number of b values 
Even more if using free breathing 
More signal averages for higher b-values 
NSA>3 increases SNR ratio 
1 
Ideally the acquisition should be good enough to allow good quality data to be acquired from a single acquisition. if absolutely;y necessary 2 signal averages 
should be the maximum. 
Comments (breathing modes) 
I would use resp. gating or triggering if scan time allowed. 
A breathhold is not feasible for long IVIM acquisitions. Free breathing saves time and is ok for allografts, navigator-gated was shown in a previous study to be 
better at controlling motion in native kidneys. Co-registration if data is necessary with either, anyway. 
For extended advanced protocols, free breathing would be preferred along with image registration; similarly if respiratory gating is not available 
free breathing for transplanted kidneys 
If patient well-trained and co-operative respiratory gating would be a reasonable option. Expiration breath-hold would prolong the acquisition time for too long 
(for whole kidney coverage) with the risk of motion artefacts / corrupted data. 
FB helpful if possible in future. 
Respiratory gated acquisition would be best but often impractical 
all three can be used 
 
Comments (cardiac gating) 
Never used for DWI 
informative for research studies but for multiparametric MR may be time prohibitive 
For advanced / research applications only - not enough data available in the area for confident assessment. However, it would make sense, in the future, to have 
this incorporated. 
have not explored the cardiac gating if it makes a difference 
 
Comments (separate vs. combined protocols) 
If you combine protocols you save a lot of time 
Ideally, there should be a single protocol for all metrics, although it may be more difficult to implement. Protocols for mpMRI and exploratory diffusion research 
can be different, but the goal should be to integrate the result of the exploratory research into mpMRI. 
Single protocol time-efficient but requires specialist processing 
if possibile all metrics in a single protocol 
Provided that the focus is a DWI / DTI / IVIM acquisition - it is difficult to see how other more advanced imaging sequences could be fitted in in addition to this 
protocol and anatomical imaging (maybe BOLD / T1 mapping could be "squeezed in"). 
Preferably one single protocol to provide all metrics for both exploratory DWI reserch, and multiparametric acquisitions 
 
Comments (DWI number of b-values) 
I mean 2 non-zero b-values in addition to the b=0 s/mm2 non diffusion-weighted baseline scan (having a relatively simple clinical protocol in mind) 
At least 3 b-values samples the exponential curve and provides better ADC values. 
For IVIM severla low b-values (below 100) are needed 
min. 3 per directions 
 
Comments (ADC low b-value inclusion) 
Ok to see the perfusion effect on ADC. Can do IVIM if we want to separate the diffusion effect from perfusion. 
allows some sensitivity to flow effects which are typically relevant; helpful to include even if ADC only is collected 
for pseudodiffusion 
 
Comments (ADC highest b-value) 
limited by gradient hardware 
I am happy with highest on the range of [600-800] s/mm2 but having to choose only one for consistency I went with 800 s/mm2 
Values above 1000 would need DKI fit of signal. 
700-1000 
b=800 seems to be sufficient for kidneys. b1000 images look noisy. 
 
Comments (IVIM number of b-values) 
Low number of b values makes it impossible to use a segmented fitted approach (which seems to me the best option) 
Currently using 9 b-values, have not performed a study to see if fewer can be used. 
8 samples should be sufficient once IVIM model has already been selected for use 
If one is interrested in the perfusion fraction f solely (not in D*), 6 b-values might suffice. 
the more b-values (especially low ones) the better, however problem of time in daily routine 
considering possible 3 diff. components including tubuli 
 
Comments (DTI number of b-values) 
I mean 2 non-zero b-values in addition to the b=0 s/mm2 non diffusion-weighted baseline scan (having a relatively simple clinical protocol in mind) 
I have never performed DTI 
a minimal set that would allow comparison of diffusivities from other protocols 
 
Comments (DTI highest b-value) 
I am happy with highest on the range of [600-800] s/mm2 but having to choose only one for consistency I went with 800 s/mm2 
 
Comments (DTI number of directions) 
Dependent on scan time and number of averages in each direction. I would recommend 12 as a minimum 
6 is the minimum, the more the better, with acquisition time as the limitation. 
a compromise of time and SNR 
6 Directions for the fractional anisotropy, tractography likely requires more. 
 
Comments (image quality control) 
Distortion correction would be helpful in some cases but not sure distortion correction tools are mature enough for renal clinical applications so probably would 
not recommend using it as the default approach. Unilateral motion correction seems mandatory to me if doing rigid registrations as the kidneys do move 
independently to a significant extent. 
Unilateral correction more difficult to be performed 
Not sure what is meant by unilateral motion correction: for 1 kidney only? 
unilateral correction essential (in free breathing protocol) given independent motion 
QA / QC should be implemented at acquisition level in the first instance so that the radiographers are well trained and recognise if an acquisitions needs to be 
repeated to achieve high quality data. 
 
Comments (map for manual ROIs) 
Recommending a method for ROI choice is not trivial. If the cortico-medullary differentiation is still possible (may depend on CKD stage) AND data has been 
properly acquired and motion-corrected, the FA maps provide a good source of contrast to readily differentiate cortex and medulla. If not, I would resort to 
drawing in the b0 map. 
Rather place ROI on b0 rather than maps, to avoid artifacts. 
FA map useful for medulla selection when DTI is available 
Why not semi-automatic? I think we are still quite far from automatic ROI placement. 
 
Comments (shape of manual ROIs) 
Continuous cortex and multiple medulla ROIs as default. The exception would be if cysts or other structural abnormalities exist which would not allow one to 
draw a continuous cortical ROI. 
Using multiple ROIs rather one large one allows avoidance of artifacts. Cortex and medulla ROI should be separated, as they have different vascularisation and 
physiological properties. Although there is poor contrast to differentiate Cx from 
Med on diffusion, anatomical images can be used as reference. 
large ROIs best use of available data 
Medulla-wedge shaped, cortical curvilinear 
Circles or any other shape as long as they confidently select anatomically-correct parts of the cortex / medulla. Why not use anatomical imaging, well-registered 
with ethical DWI / ADC / etc, with good cortico-medullary contrast to guide this process? 
Shape of the manual ROIs should aline with the anatomicl shape of cortex and medull 
 
Comments (slices for ROI sampling) 
More is better but drawing ROIs manually is a laborious process so I'd say sampling from 3 slices not a dealbreaker. 
Depends on the slice thickness. 
In my case I use 5mm thickness + 1 mm gap; taking 3 slices (central + slice before and after) you already have a representative portion of the cortex and medulla. 
For whole kidney I would suggest to remove the first and last slice and take all the others 
 
Comments (automatic ROI placement) 
Most automatic methods depend on cortico-medullary differentiation existing. In patients this may be an issue. However as mentioned above where this exists the 
FA maps provide a good source of contrast. 
dangerous - highly affected by artefacts 
Automatic ROI placement might become possible using AI methods in the future. Presently, I don't think automatic approaches based on histograms are reliable. 
supervised ROI placement is essential. Automatic may be attempted if software allows. Our software doesn't allow automatic yet. we are working on developing 
an automated version. 
 
Comments (acquisition details reporting) 
Other things to report: scanner vendor/model; field strength; fat suppression used (yes or no at least); any physiological triggering/gating if used; bandwidth; echo-
spacing; slice gap if used; order of acquisition of slices (sequential/interleaved); if undersampling was used (either partial Fourier and/or parallel imaging). This 
may sound like a lot, but it is generally hard to replicate protocols from papers if they are not comprehensive. 
parallel imaging factor, receiver bandwidth 
Maybe all these parameters should be "assembled" as a guide to reviewers and be a "requirement" for future submissions in the field (that could be adopted by 
journals, such as JMRI / MRM). 
Most of these specific acquisition details are quite general, and might be more suited for the general PARENCHIMA paper as discussed in Aarhus. 
 
Comments (processing details reporting) 
in addition: ROI used (whole kidney/cortex/medulla vs multiple ROIs, manual vs automatic ROI) 
Do not have experience with ivim 
Most of these specific postprocessing details are quite general, and might be more suited for the general PARENCHIMA paper as discussed in Aarhus. 
 
Comments (regional metrics reporting) 
Like to separate cortex from medulla 
As many metrics as possible should be reported - this is the only way in which the best parameters / biomarkers will emerge as potential candidates for clinical 
translation. 
 
Comments (diffusion units reporting) 
microns^2/ms can make the text cleaner but not standard so may still confuse people especially as bvals almost always referred to as s/mm^2 
I do not use smaller units, but they may be better as they would highlight differences in ADC or D without having to use many decimals. 
 
Comments (summary statistics reporting) 
Elaborate on single-subject vs. group metrics (e.g. stdev) 
DWI biomarkers often have non-normal distribution 
Partly depends on the distribution of the data 
 
Comments (parametric map presentation) 
Grayscale seems to be standard especially for FA, but if using colorscale use perceptually linear ones (not jet!). Fusion can be nice but would not recommend as 
the default approach. 
Maps and maps + anatomy fusions are great for presentation purposes. 
fusion challenging given EPI distortion; grayscale most standardizable 
This depends on the local preference, looks nice, but no real benefit 
